GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InventisBio Co Ltd (SHSE:688382) » Definitions » Net Interest Income

InventisBio Co (SHSE:688382) Net Interest Income : ¥36.34 Mil (TTM As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is InventisBio Co Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. InventisBio Co's net interest income for the three months ended in Sep. 2024 was ¥4.44 Mil. Its net interest income for the trailing twelve months (TTM) ended in Sep. 2024 was ¥36.34 Mil.

InventisBio Co Net Interest Income Historical Data

The historical data trend for InventisBio Co's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InventisBio Co Net Interest Income Chart

InventisBio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Interest Income
Get a 7-Day Free Trial 0.10 0.43 11.41 15.11 32.85

InventisBio Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.73 18.00 8.14 5.77 4.44

InventisBio Co Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥36.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InventisBio Co Net Interest Income Related Terms

Thank you for viewing the detailed overview of InventisBio Co's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

InventisBio Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InventisBio Co Ltd (SHSE:688382) » Definitions » Net Interest Income
Comparable Companies
SHSE:600645 SHSE:688739 SHSE:600866 SHSE:688443 SZSE:301207 SZSE:002287 SHSE:688105 SHSE:688076 SZSE:000990 SHSE:688068 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No. 4, Lane 67, Li Bing Road, Room 210, Pilot Free Trade Zone, Shanghai, CHN, 201203
Website
http://www.inventisbio.com
InventisBio Co Ltd is an innovative drug research and development enterprise based in China with a global perspective, focusing on major diseases such as tumors and metabolic diseases. It has independently developed a series of innovative targeted drugs with patent protection, covering non-small cell lung cancer, breast cancer, colorectal cancer and other solid tumors, as well as hyperuricemia and metabolic diseases such as gout.

InventisBio Co Headlines

No Headlines